Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury.
about
The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunityEffects of complement activation on allograft injuryWiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and functionActivation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.Antihyperlipidemic and Antioxidant Effects of C-phycocyanin in Golden Syrian Hamsters Fed with a Hypercholesterolemic Diet.The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine.Transplantation and Damage-Associated Molecular Patterns (DAMPs).DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing.The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications.Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury.Natural antibody - Biochemistry and functions.The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy.Refinement of tourniquet-induced peripheral ischemia/reperfusion injury in rats: comparison of 2 h vs 24 h reperfusion.Anti-LG3 Antibodies Aggravate Renal Ischemia-Reperfusion Injury and Long-Term Renal Allograft Dysfunction.Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.
P2860
Q26864215-69FAB099-1793-4D18-917F-C97E453FEC81Q26995453-8380140C-D48A-42E2-A2BF-1B4536B65188Q28512842-8ADA029B-81A1-4DA9-ABF1-910D3E1EA7C3Q33852943-A0177D11-510D-4046-82E0-BDE284585D2CQ36374030-CA2C09D3-5B5E-44C9-8268-9BD06D0AD6DEQ36969817-97A15FBD-C68D-457B-9300-C03258A876A7Q37585308-78CF4314-7D41-4E46-8B58-5FC2A987E403Q38519934-F30BA84D-B688-48FA-96F4-81EC3A16B1DEQ38898214-3414DAB3-B482-4149-875F-224E5B6A4FD8Q38928826-0ACBAFDD-5861-4411-A5E1-1AE80FC60F87Q38995184-466AD65D-EB6A-468B-8500-103AF3F2E340Q42225361-6CA0823A-C21B-4C98-A078-909B1E9E0A4CQ42934450-519BFD66-9EE2-4590-9E77-FEF215A27E9DQ46248218-3A856BC7-740D-4A88-B584-B5E5CA8ABAE4Q47904887-D10A4E7B-7640-4D04-8A22-08E523DB146EQ48055653-283102E4-1364-4839-A1FF-8E2C8A2B3EEDQ52559151-A3EBAD8E-61D5-4C5B-AE87-6A25682746CD
P2860
Natural IgM-mediated innate autoimmunity: a new target for early intervention of ischemia-reperfusion injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Natural IgM-mediated innate au ...... f ischemia-reperfusion injury.
@en
type
label
Natural IgM-mediated innate au ...... f ischemia-reperfusion injury.
@en
prefLabel
Natural IgM-mediated innate au ...... f ischemia-reperfusion injury.
@en
P2860
P1476
Natural IgM-mediated innate au ...... f ischemia-reperfusion injury.
@en
P2093
Michael C Carroll
Ming Zhang
P2860
P304
P356
10.1517/14712598.7.10.1575
P407
P577
2007-10-01T00:00:00Z